Analysis of Adiponectin, TNF-α, and Biochemical Markers in Fallujah Atherosclerosis Patients

Amenh Muhammed Abdulrahman

doi:10.61132/obat.v3i3.1377

Authors

Amenh Muhammed Abdulrahman Al-Iraqia university

DOI:

https://doi.org/10.61132/obat.v3i3.1377

Keywords:

Atherosclerosis, Inflammatory cytokines, Metals, PAI-1

Abstract

Background: Atherosclerosis is a chronic inflammatory cardiovascular disorder strongly associated with elevated low-density lipoprotein cholesterol (LDL-C) levels and serves as a major predictor of adverse cardiovascular events. This study aimed to investigate the relationship between inflammatory markers (adiponectin and TNF-α) and key biochemical parameters in atherosclerosis patients. Methods: A case-control study was conducted on 60 participants (aged 40–65 years) recruited from private cardiac clinics in Fallujah, Iraq, between October and December 2024. Subjects were stratified into two groups: 30 atherosclerosis patients (diagnosed by specialists) and 30 age-matched healthy controls. Blood samples were collected, centrifuged, and analyzed for CRP, TNF-α, adiponectin, PAI-1, MDA, GSH, sodium (Na), and magnesium (Mg) levels using standardized biochemical assays. Statistical analysis was performed using SPSS, with significance set at *p* ≤ 0.001. Results: Atherosclerosis patients exhibited significantly elevated serum levels of CRP (2.21 ± 14.46 vs. 1.07 ± 7.76 mg/dL), TNF-α (15.14 ± 120.86 vs. 4.27 ± 65.16 pg/mL), PAI-1 (6.52 ± 0.82 vs. 2.02 ± 0.42 ng/dL), MDA (590.26 ± 29.64 vs. 155.52 ± 25.19 ng/mL), and Na (140.16 ± 1.18 vs. 125.46 ± 6.17 nmol/L) compared to controls (*p* ≤ 0.001). Conversely, adiponectin (0.18 ± 1.81 vs. 0.67 ± 4.18 mg/dL), GSH (22.79 ± 1.37 vs. 40.81 ± 3.05 μg/mL), and Mg (1.46 ± 0.175 vs. 1.84 ± 0.67 nmol/L) were markedly reduced in patients. ROC curve analysis demonstrated perfect diagnostic accuracy (AUC = 1.0) for CRP, TNF-α, and adiponectin in distinguishing patients from controls. Conclusion: The study highlights pronounced dysregulation of inflammatory, oxidative, and metabolic pathways in atherosclerosis, with CRP, TNF-α, and adiponectin serving as robust discriminative biomarkers. These findings underscore the potential of targeting these pathways for therapeutic intervention and early diagnosis.

Downloads

Download data is not yet available.

References

AL-Barzinji, R. M., & Rahman, L. Q. (2017). Evaluate the correlation of inflammatory cytokines with Chlamydia pneumoniae in coronary atherosclerotic patients. Journal of the Faculty of Medicine, 59(3), 262–267.

Amin, M. N., Siddiqui, S. A., Uddin, M. G., et al. (2020). Increased oxidative stress, altered trace elements, and macro-minerals are associated with female obesity. Biological Trace Element Research, 197(2), 384–393. https://doi.org/10.1007/s12011-019-02002-z

Björkegren, J. L., & Lusis, A. J. (2022). Atherosclerosis: Recent developments. Cell, 185(10), 1630–1645.

Blaum, C., Brunner, F. J., Kröger, F., et al. (2021). Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target population. European Journal of Preventive Cardiology, 28(2), 152–158.

Chen, Y., Zheng, Y., Liu, L., et al. (2017). Adiponectin inhibits TNF-α-activated PAI-1 expression via the cAMP-PKA-AMPK-NF...

Choi, H. M., Doss, H. M., & Kim, K. S. (2020). Multifaceted physiological roles of adiponectin in inflammation and diseases. International Journal of Molecular Sciences, 21(4). https://doi.org/10.3390/ijms21041219

Córdova-Pérez, N., Basurto-Acevedo, L., Degollado-Córdova, J. A., et al. (2015). Menopausal women have hypofibrinolysis even in subclinical stage of atherosclerosis. Revista de Investigación Clínica, 67(2), 122–129.

Denegri, A., & Boriani, G. (2021). High-sensitivity C-reactive protein (hsCRP) and its implications in cardiovascular outcomes. Current Pharmaceutical Design, 27(2), 263–275.

Duan, H., Zhang, Q., Liu, J., et al. (2021). Suppression of apoptosis in vascular endothelial cells: The promising way for natural medicines to treat atherosclerosis. Pharmaceutical Research, 168, 105599.

Fu, Y., Wu, Y., & Liu, E. (2020). C-reactive protein and cardiovascular disease: From animal studies to the clinic. Experimental and Therapeutic Medicine, 20(2), 1211–1219.

Garcia, C., & Blesso, C. N. (2021). Antioxidant properties of anthocyanins and their mechanism of action in atherosclerosis. Free Radical Biology and Medicine, 172, 152–166.

Iketani, M., Sekimoto, K., Igarashi, T., et al. (2018). Administration of hydrogen-rich water prevents vascular aging of the aorta in LDL receptor-deficient mice. Scientific Reports, 8(1), 16822.

Jebari-Benslaiman, S., Galicia-García, U., Larrea-Sebal, et al. (2022). Pathophysiology of atherosclerosis. Journal of Molecular Sciences, 23(6), 3346.

Khoramipour, K., Chamari, K., Hekmatikar, A. A., et al. (2021). Diseases, and effects of nutrition. 1–15.

Lamb, F. S., Choi, H., Miller, M. R., & Stark, R. J. (2020). TNFα and reactive oxygen signaling in vascular smooth muscle cells in hypertension and atherosclerosis. American Journal of Hypertension, 33(10), 902–913.

Li, X., Zhang, F., Zhou, H., et al. (2020). Interplay of TNF-α, soluble TNF receptors and oxidative stress in coronary chronic total occlusion of the oldest patients with coronary heart disease. Cytokine, 125, 154836.

Lim, S., & Park, S. (2014). Role of vascular smooth muscle cell in the inflammation of atherosclerosis. BMB Reports, 47(1), 1.

López-Ortega, O., Moreno-Corona, N. C., Cruz-Holguín, V. J., et al. (2022). The immune response in adipocytes and their susceptibility to infection: A possible relationship with infectobesity. International Journal of Molecular Sciences, 23(11). https://doi.org/10.3390/ijms23116154

Melnikov, I. S., Kozlov, S. G., Saburova, O. S., et al. (2020). Current position on the role of monomeric C-reactive protein in vascular pathology and atherothrombosis. Current Pharmaceutical Design, 26(1), 37–43.

Melnikov, I., Kozlov, S., Saburova, O., et al. (2023). Monomeric C-reactive protein in atherosclerotic cardiovascular disease: Advances and perspectives. Journal of Molecular Sciences, 24(3), 2079.

Meshkini, M., Alaei-Shahmiri, F., Mamotte, C., & Dantas, J. (2018). Ethnic variations in adiponectin levels and its association with age, gender, body composition and diet: Differences between Iranians, Indians and Europeans living in Australia. Journal of Immigrant and Minority Health, 20(6), 1362–1372. https://doi.org/10.1007/s10903-018-0706-9

Mihalopoulos, N. L., Yap, J. T., Beardmore, B., et al. (2020). Cold-activated brown adipose tissue is associated with less cardiometabolic dysfunction in young adults with obesity. Obesity, 28(5), 916–923. https://doi.org/10.1002/oby.22767

Murakami, T. (2023). Atherosclerosis and arteriosclerosis. Hypertension Research, 46(7), 1810–1811.

Nigro, E., Scudiero, O., Monaco, M. L., et al. (2014). New insight into adiponectin role in obesity and obesity-related diseases. BioMed Research International, 2014. https://doi.org/10.1155/2014/658913

Poredos, P., Poredos, A. V., & Gregoric, I. (2021). Endothelial dysfunction and its clinical implications. Angiology, 72(7), 604–615. https://doi.org/10.1177/0003319720987752

Saigusa, R., Winkels, H., & Ley, K. (2020). T cell subsets and functions in atherosclerosis. Nature Reviews Cardiology, 17(7), 387–401.

Scheen, A. J. (2018). From atherosclerosis to atherothrombosis: from a silent chronic pathology to an acute critical event. Revue Médicale de Liège, 73(5–6), 224–228.

Sun, W., Xu, Y., Yao, Y., et al. (2022). Self-oxygenation mesoporous MnO₂ nanoparticles with ultra-high drug loading capacity for targeted arteriosclerosis therapy. Journal of Nanobiotechnology, 20(1), 88.

Vasan, R. S., Pan, S., Larson, M. G., Mitchell, G. F., & Xanthakis, V. (2021). Arteriosclerosis, atherosclerosis, and cardiovascular health: Joint relations to the incidence of cardiovascular disease. Hypertension, 78(5), 1232–1240.

Wang, H. H., Garruti, G., Liu, M., Portincasa, P., & Wang, D. Q. H. (2017). Cholesterol and lipoprotein metabolism and atherosclerosis: recent advances in reverse cholesterol transport. Annals of Hepatology, 16(Suppl 1), S27–S42.

Yang, X., Zhang, D., Zhao, Y., et al. (2021). Association between serum level of C-reactive protein and risk of cardiovascular events based on cohort studies. Journal of Human Hypertension, 35(12), 1149–1158.

Zhang, L. (2020). Cyclodextrin-related drug delivery system to promote atherosclerosis regression. Die Pharmazie - Journal of Pharmaceutical Sciences, 75(12), 619–625.

Zhu, Y., Xian, X., Wang, Z., et al. (2018). Research progress on the relationship between atherosclerosis and inflammation. Biomolecules, 8(3), 80.